Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor

F. Janku, E. J. Sherman, A. R. Parikh, L. G. Feun, F. Tsai, E. Allen, C. Zhang, P. Severson, K. Inokuchi, J. Walling, S. Averbuch, G. Tarcic, G. Bollag

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)S2-S3
JournalEuropean Journal of Cancer
Volume138
DOIs
StatePublished - Oct 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this